• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Mortality from neurodegenerative disease may be higher among former professional soccer players

byNiki WintersandDeepti Shroff
November 17, 2019
in Chronic Disease, Neurology, Public Health
Reading Time: 2 mins read
Myeloperoxidase upregulation in epileptogenesis seen on molecular imaging
Share on FacebookShare on Twitter

1. In this retrospective cohort study, mortality from neurodegenerative disease was higher among former professional soccer players than the control group. Mortality related to ischemic heart disease and lung cancer was lower.

2. Former professional soccer players were prescribed dementia-related medications more frequently than the control group.

Evidence Rating Level: 2 (Good)

Study Rundown: Attention has been raised about the risks of neurodegenerative diseases among athletes in contact sports, especially soccer since it is popular worldwide. While the neurocognitive consequences of contact sports are uncertain, the overall health benefits of physical activity, like reduction in cardiovascular disease, have been established. A retrospective cohort study was conducted to compare mortality from neurodegenerative disease among former soccer players with than among controls. Causes of death were obtained from death certificates and data on dementia-related medications were collected. Overall mortality rate was lower among former soccer players up to the age of 70 years and was higher thereafter as compared to controls. Mortality from neurodegenerative disease was higher in former soccer players, while mortality from ischemic heart disease and lung cancer was lower. Median age of death was a few years higher in former soccer players as compared to controls. In addition, medications for dementia were more common among former soccer players than controls. Given that this study only included prescribing outcomes from 2009 onwards, only contained data on males, and was a retrospective study, more research needs to be done to confirm mortality rates, causes, and the use of dementia-related medications among soccer players.

Click to read the study in NEJM

Relevant Reading: Mortality Among Professional American-Style Football Players and Professional American Baseball Players

RELATED REPORTS

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

In-Depth [retrospective cohort]: A retrospective cohort study was performed to determine mortality causes and rates among male Scottish professional soccer players. All males born before January 1977 were eligible for the study and included data up to December 2016. Data on the primary and contributory causes of death were obtained from death certificates and data on medications were obtained from the Prescribing Information System from 2009 onward. The overall mortality rate was lower among soccer players than the control groups (15.4% vs. 16.5%; hazards ratio, 0.87; 95% CI, 0.80 to 0.93; P<0.001). Mortality from neurodegenerative disease as the primary cause of death was higher among soccer players than the controls (1.7% vs. 0.5%; hazards ratio 4.10; 95% CI, 2.88 to 5.83; P<0.001), but did not differ significantly between goalkeepers and outfield players. Prescriptions for dementia-related medications were more common among former soccer players than controls (odds ratio, 4.90; 95% CI, 3.81 to 6.31; P<0.001), but less common among goal-keepers than outfield players. Of note the median age of death was 67.9 years among soccer players and 64.7 years among the controls. Mortality rates resulting from ischemia heart disease and lung cancer were lower among soccer players. Mortality rates resulting from stroke and cerebrovascular disease and age at death from neurodegenerative disease did not differ significantly between the two groups.

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiovascular diseasefootballmortalityneurodegenerative diseasesoccer
Previous Post

Dengue fever vaccine candidate (TAK-003) offers significant protection in trials

Next Post

#VisualAbstract: Metoprolol for the Prevention of Acute Exacerbations of COPD

RelatedReports

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
“Housing First” linked to housing stability for homeless youth with mental illness
Public Health

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

August 31, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

August 4, 2026
Collage of medical tech icons circling a central chip with 'AI Roundup' title and 2 Minute Medicine logo in teal background.
AI Roundup

2MM: AI Roundup: NHS England expands Microsoft Copilot nationwide, ARPA-H advances autonomous cardiovascular AI, FDA advisors back Moderna’s mRNA influenza vaccine, and UpDoc earns first clearance for a patient-facing large language model

September 3, 2026
Next Post
#VisualAbstract: Metoprolol for the Prevention of Acute Exacerbations of COPD

#VisualAbstract: Metoprolol for the Prevention of Acute Exacerbations of COPD

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

Testosterone therapy linked to increased risk of venous thromboembolism

Greater prenatal alcohol exposure trajectories linked to impaired growth and neurodevelopment

Developmental assessment at 9 months of age can predict fetal alcohol syndrome

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
  • Real-time AI guidance enters live brain tumor surgery
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.